Topic summary

Restarting after a long gap: what the labelling implies

Practice › Dosing & titration dose reduction semaglutide titration missed dose worked example

This is a generated summary. It shows the 7 most-liked posts from a topic of 47, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

endpoint_lineTL3Regular27 Jun 2026#3

r.bruun, post #1: Posting this under the heading it deserves: Restarting after a long gap: what the labelling implies Everything below is what sits behind that. I have read the maintained page on this and I still have a gap, so I am asking rather than guessing. Context: tirzepatide, 14 weeks in, currently at a dose I reached by the standard four-week… Go to post

Picking up the opening post: that is the part I would want checked first.

Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.

Written quickly, so the reasoning may be tighter than the wording.

23 likes in reply to #1 1mo

d.ndiayeTL21 Jul 2026#8

Worth separating two things that post #6 runs together.

Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.

One of those cases where knowing the mechanism does not help the decision.

31 likes 27d

b.correiaTL25 Jul 2026#13

The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The reasoning is pharmacological — e.g., "I will split the difference between steps" — but it is reasoning from theory, not from evidence.

32 likes 22d

c.serranoTL28 Jul 2026#17

Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by real-world reports. The dose does not seem to stop working, but the longest trials are not indefinitely long.

The evidence for this is thinner than the way I have phrased it suggests.

24 likes 20d

r.girardTL212 Jul 2026#22

Answering the question post #20 raises rather than the one it answers.

Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.

24 likes in reply to #1 16d

unit_conversionTL3Regular20 Jul 2026#35

a.eriksen, post #15: The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong thing. Go to post

Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.

That is one dataset and I would not build a rule on it.

30 likes in reply to #15 8d

ar.kravchenkoTL224 Jul 2026#42

Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.

27 likes 4d

Read the full topic (47 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Practice › Dosing & titration dose reduction semaglutide titration Wiki Posting this under the heading it deserves: Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Everything below is what sits behind that. I have read the maintained page…	+138	148	1.8k	2y
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Practice › Dosing & titration missed dose tirzepatide dose reduction titration Solved Asking directly, because I could not find a straight answer: Reaching a dose and staying there for a year: a longitudinal note — does this still hold? I have read the maintained page on this and I still have…	+35	39	547	11mo
How the published trials escalated, tabulated side by side — does this still hold? Practice › Dosing & titration dose reduction tirzepatide missed dose Solved Asking directly, because I could not find a straight answer: How the published trials escalated, tabulated side by side — does this still hold? Asking about published trials escalated directly, because I have…		2	8.9k	9mo
When a dose reduction is the correct response to a side effect — a second dataset Practice › Dosing & titration worked example dose reduction titration tirzepatide When a dose reduction is the correct response to a side effect — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Posting a small dataset on dose…	+10	14	42k	2mo
Follow-up: Escalating every six weeks instead of four: what I observed over eight months Practice › Dosing & titration titration worked example tirzepatide dose reduction Escalating every six weeks instead of four: what I observed over eight months — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…		4	164	20mo

Related topics — sharing the tags dose reduction, semaglutide, titration

Topic	Participants	Replies	Views	Activity
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Devices › Pens & autoinjectors dead volume missed dose storage subcutaneous injection Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Writing it up because I had to work it out twice and would rather nobody else did. Question about a metering device rather…		2	18k	6h
Reading a syringe in poor light, and how to avoid needing to — what changed since Devices › Syringes & needles dead volume subcutaneous injection syringe units needle gauge & length Posting this under the heading it deserves: Reading a syringe in poor light, and how to avoid needing to — what changed since Everything below is what sits behind that. What changes if the standard account of…	+3	7	27k	27d
Dead volume across syringe and needle combinations Devices › Syringes & needles needle gauge & length subcutaneous injection dead volume syringe units On the subject in the title: Dead volume across syringe and needle combinations Working notes rather than a conclusion. Something about dead volume across syringe does not reconcile and I would like a second…	+72	80	28k	5mo
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Practice › Dosing & titration dose reduction worked example tirzepatide missed dose Solved Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept I have read the maintained page on this and I still have a gap, so I…	+7	11	26k	9mo
Follow-up: Dead volume across syringe and needle combinations Devices › Syringes & needles syringe units worked example subcutaneous injection dead volume Solved Dead volume across syringe and needle combinations — setting out what I have, and where I think it stops being reliable. A follow-up question about Dead volume across syringe that I did not know to ask the…	+81	98	22k	18mo